NOD2 and breast carcinoma: Many studies have shown that mutation of NOD2 is closely related to inflammatory bowel disease, intestinal cancer, breast cancer and even endometrial carcinoma (Zhang et al. 2020; Huszno et al. 2020; Hoffmann et al. 2021).